151 related articles for article (PubMed ID: 30993827)
1. Effect of Low-Density Lipoprotein Apheresis for Nephrotic Idiopathic Membranous Nephropathy as Initial Induction Therapy.
Koshi-Ito E; Koike K; Tanaka A; Watanabe Y; Kamegai N; Shimogushi H; Shinjo H; Otsuka Y; Inaguma D; Takeda A
Ther Apher Dial; 2019 Dec; 23(6):575-583. PubMed ID: 30993827
[TBL] [Abstract][Full Text] [Related]
2. Long-term Low-density Lipoprotein Apheresis in a Patient with Refractory Idiopathic Membranous Glomerulonephritis.
Yabuuchi J; Suwabe T; Mizuno H; Ueno T; Hoshino J; Sekine A; Kawada M; Yamanouchi M; Hayami N; Hiramatsu R; Hasegawa E; Sawa N; Takaichi K; Fujii T; Ohashi K; Ubara Y
Intern Med; 2017; 56(12):1543-1547. PubMed ID: 28626181
[TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein apheresis therapy for steroid- and cyclosporine-resistant idiopathic membranous nephropathy.
Sato Y; Tsunoda S; Nozue T; Pan Q; Wakasugi H; Yoshimura A
Intern Med; 2012; 51(18):2597-602. PubMed ID: 22989833
[TBL] [Abstract][Full Text] [Related]
4. Rapid normalization of interleukin-8 production after low-density lipoprotein apheresis in steroid-resistant nephrotic syndrome.
Sakurai M; Muso E; Matushima H; Ono T; Sasayama S
Kidney Int Suppl; 1999 Jul; 71():S210-2. PubMed ID: 10412778
[TBL] [Abstract][Full Text] [Related]
5. Treatment-resistant PLA2R-negative membranous nephropathy responsive to low-density lipoprotein apheresis.
Szymanski JM; Waldman M; Conry-Cantilena C; West KA
J Clin Apher; 2019 Aug; 34(4):495-498. PubMed ID: 30537217
[TBL] [Abstract][Full Text] [Related]
6. Effect of low-density lipoprotein-apheresis on nephrotic syndrome due to membranous nephropathy in renal allograft: a case report.
Ideura T; Hora K; Kaneko Y; Yamazaki T; Tokunaga S; Shigematsu H; Kiyosawa K
Transplant Proc; 2000 Feb; 32(1):223-6. PubMed ID: 10701029
[No Abstract] [Full Text] [Related]
7. Does LDL-apheresis in steroid-resistant nephrotic syndrome affect prognosis?
Muso E; Yashiro M; Matsushima M; Yoshida H; Sawanishi K; Sasayama S
Nephrol Dial Transplant; 1994; 9(3):257-64. PubMed ID: 8052431
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein apheresis for PLA2R-related membranous glomerulonephritis accompanied by IgG4-related tubulointerstitial nephritis.
Nishizawa Y; Honda K; Aoyama Y; Hosoda Y; Tamura T; Horimoto A; Omae K; Higuchi C; Sakura H; Nitta K; Ogawa T
CEN Case Rep; 2020 Nov; 9(4):395-403. PubMed ID: 32557252
[TBL] [Abstract][Full Text] [Related]
9. Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome. Kansai-FGS-Apheresis Treatment (K-FLAT) Study Group.
Muso E; Mune M; Fujii Y; Imai E; Ueda N; Hatta K; Imada A; Miki S; Kuwahara T; Takamitsu Y; Takemura T; Tsubakihara Y
Kidney Int Suppl; 1999 Jul; 71():S122-5. PubMed ID: 10412754
[TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein apheresis in a pediatric patient with refractory nephrotic syndrome due to focal segmental glomerulosclerosis.
Oto J; Suga K; Matsuura S; Kondo S; Ohnishi Y; Inui D; Imanaka H; Kagami S; Nishimura M
J Anesth; 2009; 23(2):284-7. PubMed ID: 19444573
[TBL] [Abstract][Full Text] [Related]
11. A combined low-density lipoprotein apheresis and prednisone therapy for steroid-resistant primary focal segmental glomerulosclerosis in children.
Hattori M; Chikamoto H; Akioka Y; Nakakura H; Ogino D; Matsunaga A; Fukazawa A; Miyakawa S; Khono M; Kawaguchi H; Ito K
Am J Kidney Dis; 2003 Dec; 42(6):1121-30. PubMed ID: 14655182
[TBL] [Abstract][Full Text] [Related]
12. Effect of low-density lipoprotein apheresis on urinary protein and podocyte excretion in patients with nephrotic syndrome due to diabetic nephropathy.
Nakamura T; Kawagoe Y; Ogawa H; Ueda Y; Hara M; Shimada N; Ebihara I; Koide H
Am J Kidney Dis; 2005 Jan; 45(1):48-53. PubMed ID: 15696443
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting the long-term outcomes of idiopathic membranous nephropathy.
Huh H; Lee H; Lee JP; Kim DK; Oh S; Oh YK; Kim YS; Lim CS
BMC Nephrol; 2017 Mar; 18(1):104. PubMed ID: 28347297
[TBL] [Abstract][Full Text] [Related]
14. A case report of nephrotic syndrome due to collapsing focal segmental glomerulosclerosis treated with low-density lipoprotein apheresis.
Miyazono M; Tomiyoshi Y; Kishi T; Ikeda Y; Sakemi T; Sanai T; Node K
Ther Apher Dial; 2008 Aug; 12(4):333-6. PubMed ID: 18789122
[TBL] [Abstract][Full Text] [Related]
15. Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study.
Muso E; Mune M; Hirano T; Hattori M; Kimura K; Watanabe T; Yokoyama H; Sato H; Uchida S; Wada T; Shoji T; Yuzawa Y; Takemura T; Sugiyama S; Nishizawa Y; Ogahara S; Yorioka N; Sakai S; Ogura Y; Yukawa S; Iino Y; Imai E; Matsuo S; Saito T
Clin Exp Nephrol; 2015 Jun; 19(3):379-86. PubMed ID: 24934117
[TBL] [Abstract][Full Text] [Related]
16. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
[TBL] [Abstract][Full Text] [Related]
17. [Excellent antiproteinuric effect by LDL apheresis in a case with severe renal dysfunction due to focal segmental glomerulosclerosis].
Iwahori T; Yoshida M; Sugiura M; Ioya N; Kawaguchi M
Nihon Jinzo Gakkai Shi; 1996 Feb; 38(2):91-7. PubMed ID: 8717311
[TBL] [Abstract][Full Text] [Related]
18. An update on LDL apheresis for nephrotic syndrome.
Raina R; Krishnappa V
Pediatr Nephrol; 2019 Oct; 34(10):1655-1669. PubMed ID: 30218191
[TBL] [Abstract][Full Text] [Related]
19. LDL-apheresis contributes to survival extension and renal function maintenance of severe diabetic nephropathy patients: a retrospective analysis.
Sato E; Amaha M; Nomura M; Matsumura D; Ueda Y; Nakamura T
Diabetes Res Clin Pract; 2014 Nov; 106(2):241-6. PubMed ID: 25306260
[TBL] [Abstract][Full Text] [Related]
20. Low density lipoprotein apheresis ameliorates interferon-γ production in patients with nephrotic syndrome.
Miyata H; Uno K; Ono T; Yashiro M; Fukatsu A; Kita T; Kimura T; Muso E
Ther Apher Dial; 2012 Apr; 16(2):189-94. PubMed ID: 22458400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
